WallStSmart

Klarna Group plc (KLAR)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Klarna Group plc generates 1255% more annual revenue ($3.51B vs $258.90M). KLAR leads profitability with a -8.4% profit margin vs -15.5%. KLAR earns a higher WallStSmart Score of 59/100 (C).

KLAR

Buy

59

out of 100

Grade: C

Growth: 8.0Profit: 4.0Value: 8.3Quality: 3.0
Piotroski: 1/9Altman Z: 0.38

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KLARUndervalued (+55.6%)

Margin of Safety

+55.6%

Fair Value

$43.04

Current Price

$13.92

$29.12 discount

UndervaluedFair: $43.04Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KLAR4 strengths · Avg: 9.0/10
PEG RatioValuation
0.1010/10

Growing faster than its price suggests

Revenue GrowthGrowth
38.4%10/10

Revenue surging 38.4% year-over-year

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.5%8/10

Strong operational efficiency at 20.5%

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KLAR4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Return on EquityProfitability
-11.1%2/10

ROE of -11.1% — below average capital efficiency

Free Cash FlowQuality
$-3.04B2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KLAR

The strongest argument for KLAR centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 38.4% demonstrates continued momentum. PEG of 0.10 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KLAR

The primary concerns for KLAR are EPS Growth, Piotroski F-Score, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KLAR scores higher overall (59/100 vs 41/100) and 38.4% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Klarna Group plc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Klarna Group plc is a technology-driven payments company in the United Kingdom, the United States, Germany, Sweden, and internationally. The company is headquartered in London, United Kingdom.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?